Last Updated: August, 2024
Trusted by 200+ Clients
The report provides a detailed analysis essential for establishing a Cobimetinib production plant. It encompasses all critical aspects necessary for Cobimetinib production, including the cost of Cobimetinib production, Cobimetinib plant cost, Cobimetinib production costs, and the overall Cobimetinib production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Cobimetinib production plant.
These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Cobimetinib is an anticancer medication used to treat a type of skin cancer called melanoma when it has spread to other parts of the body or cannot be completely removed by surgery. It functions by blocking a protein called mitogen-activated extracellular kinase (MEK) that is involved in the growth and spread of cancer cells.
Cobimetinib is also used in combination with vemurafenib (a targeted therapy that works by blocking a mutated protein called BRAF). It is also utilized to treat an uncommon type of blood cancer called histiocytic neoplasms in adults. It is also utilized to treat an uncommon type of blood cancer called histiocytic neoplasms in adults.
The procurement of Cobimetinib is influenced by its application in the pharmaceutical and medical industries as an anticancer drug used to treat melanoma or skin cancer. The widespread occurrence of skin cancer is significantly increasing the demand for Cobimetinib.
According to clinical research, combining Cobimetinib with Vemurafenib increases overall survival (OS) and progression-free survival (PFS) more than using Vemurafenib alone. This makes the combination a favored treatment option, which drives its market expansion. Its market is further driven by the better tolerability and safety records of the combination therapy as compared to other drugs of its class, which enhances its market position.
The drug’s utility in conditions apart from melanoma, such as aiding in the treatment of colorectal cancer, also contributes to its market adoption.Overall, industrial Cobimetinib procurement is influenced by its application in the pharmaceutical and medical industries, rising cases of skin cancer, combination therapy, improvement in survival rates, better safety profile and tolerability, and regulatory approvals.
According to the Cobimetinib production plant project report, the key raw material used in the production of Cobimetinib includes tert-butyl 2-(3-hydroxyazetidin-3-yl)piperidine-1-carboxylate.
The extensive Cobimetinib production cost report consists of the following major industrial production process:
Cobimetinib, commercially known as Cotellic, is a white to off-white crystalline powder having the molecular formula C21H21F3IN3O2 and a molecular weight of 531.3 g/mol. It has an estimated water solubility of 0.0422 mg/mL. It has a log P value of 3.35. The value of its dissociation constant, pKa, is 13.37.
It is an inhibitor of mitogen-activated protein kinase and is used alongside vemurafenib to treat patients with metastatic or incurable melanoma. It belongs to the group of piperidines, as well as N-acylazetidine, tertiary alcohol, aromatic amine, difluorobenzene, secondary amino compounds, and organoiodine compounds.
Cobimetinib Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Cobimetinib |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimizing the should cost of production for Cobimetinib but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilizing a comprehensive cost model, we help you break down expenses related to raw materials, labor, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimizing the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing Cobimetinib market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
Compare & Choose the Right Report Version for You
How to Order Your Report?
